CXCL10 and HIV infectious disease: We propose a model whereby CXCL10 production is enhanced following HIV and HBV infection of hepatocytes, which can attract activated CXCR3+ NK and T-cells into the liver leading to enhanced HIV infection of T-cells, inflammation and development of fibrosis over time.